SCN-002

N/A

Report date: 2025/08/01 16:03:00

Base Information

Drug NameSCN-002
Drug Alias NameSCN-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsCardiovascular DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScicann Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesScicann Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A